Scarica l'app Stockscreener
8.93
0.11%
0.010
Dopo l'orario di chiusura:
9.12
0.19
+2.13%
Precedente Chiudi:
$8.92
Aprire:
$9.01
Volume 24 ore:
1.63M
Relative Volume:
1.38
Capitalizzazione di mercato:
$501.29M
Reddito:
$27.46M
Utile/perdita netta:
$-46.05M
Rapporto P/E:
-6.9225
EPS:
-1.29
Flusso di cassa netto:
$-33.83M
1 W Prestazione:
-3.98%
1M Prestazione:
-20.62%
6M Prestazione:
+20.84%
1 anno Prestazione:
+24.20%
Intervallo 1D:
$8.645
$9.08
Intervallo di 1 settimana:
$8.645
$9.39
Portata 52W:
$6.19
$13.16
Zevra Therapeutics Inc Stock (ZVRA) Company Profile
Nome
Zevra Therapeutics Inc
Settore
Industria
Telefono
(321) 939-3416
Indirizzo
1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION
Confronta ZVRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZVRA
Zevra Therapeutics Inc
|
8.93 | 510.83M | 27.46M | -46.05M | -33.83M | -1.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Zevra Therapeutics Inc Stock (ZVRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-01-08 | Ripresa | Cantor Fitzgerald | Overweight |
| 2024-10-07 | Iniziato | Guggenheim | Buy |
| 2024-09-24 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-09-24 | Reiterato | Maxim Group | Buy |
| 2024-04-02 | Reiterato | Maxim Group | Buy |
| 2024-03-12 | Iniziato | William Blair | Outperform |
| 2023-03-17 | Iniziato | Maxim Group | Buy |
Mostra tutto
Zevra Therapeutics Inc Borsa (ZVRA) Ultime notizie
Fund Flows: What is Zevra Therapeutics Inc.’s market positionProfit Target & Fast Momentum Stock Entry Tips - khodrobank.com
How does Zevra Therapeutics Inc. compare to its peersJuly 2025 Opening Moves & Community Verified Trade Alerts - khodrobank.com
What recovery options are there for Zevra Therapeutics Inc.2025 Historical Comparison & Precise Swing Trade Entry Alerts - Newser
Volume spikes in Zevra Therapeutics Inc. stock – what they mean2025 Market Sentiment & Weekly Stock Breakout Alerts - Newser
Quantitative breakdown of Zevra Therapeutics Inc. recent moveJuly 2025 Breakouts & AI Optimized Trade Strategies - Newser
Does Zevra Therapeutics Inc. meet Warren Buffett’s criteria2025 Market Overview & Weekly Chart Analysis and Trade Guides - khodrobank.com
Predicting Zevra Therapeutics Inc. trend using moving averages2025 Growth vs Value & AI Enhanced Trading Signals - Newser
Zevra Therapeutics Inc. stock chart pattern explained2025 Retail Activity & Verified Entry Point Signals - Newser
Using Python tools to backtest Zevra Therapeutics Inc. strategiesJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - Newser
What makes Zevra Therapeutics Inc. stock price move sharplyJuly 2025 Technicals & Verified Swing Trading Watchlists - Newser
How to manage a losing position in Zevra Therapeutics Inc.2025 Winners & Losers & Fast Exit and Entry Strategy Plans - Newser
Can Zevra Therapeutics Inc. recover in the next quarterChart Signals & Community Trade Idea Sharing Platform - Newser
Relative strength of Zevra Therapeutics Inc. in sector analysisTrade Risk Summary & Comprehensive Market Scan Insights - Newser
Measuring Zevra Therapeutics Inc.’s beta against major indices2025 Price Momentum & Target Return Focused Stock Picks - Newser
Is Zevra Therapeutics Inc. still worth holding after the dipJuly 2025 Decliners & Smart Investment Allocation Insights - Newser
Full technical analysis of Zevra Therapeutics Inc. stock2025 Key Highlights & Reliable Price Breakout Signals - Newser
Advanced analytics toolkit walkthrough for Zevra Therapeutics Inc.Jobs Report & Growth Oriented Trading Recommendations - Newser
How to build a dashboard for Zevra Therapeutics Inc. stockWeekly Stock Report & Short-Term High Return Ideas - Newser
Zevra Therapeutics gains amid takeover speculation - MSN
Is now a turning point for Zevra Therapeutics Inc.Market Risk Summary & Free Low Drawdown Momentum Trade Ideas - Newser
Is Zevra Therapeutics Inc. stock overhyped or has real potentialMarket Activity Summary & Real-Time Stock Price Movement Reports - Newser
Custom strategy builders for tracking Zevra Therapeutics Inc.2025 Buyback Activity & Fast Gain Stock Trading Tips - Newser
Is Zevra Therapeutics Inc. stock bottoming outJuly 2025 Decliners & AI Optimized Trading Strategy Guides - Newser
Real time scanner hits for Zevra Therapeutics Inc. explainedQuarterly Growth Report & Capital Efficient Trade Techniques - Newser
Analyzing drawdowns of Zevra Therapeutics Inc. with statistical toolsWeekly Trade Review & AI Driven Price Predictions - Newser
Is Zevra Therapeutics Inc. stock showing strong momentumEarnings Growth Summary & Growth Focused Stock Pick Reports - خودرو بانک
Favourable Signals For Zevra Therapeutics: Numerous Insiders Acquired Stock - Yahoo Finance
Aug Update: What are Zevra Therapeutics Inc.’s earnings expectationsTrade Performance Summary & Long-Term Safe Investment Plans - khodrobank.com
Zevra Therapeutics Inc. stock retracement – recovery analysisVolume Spike & Real-Time Price Movement Reports - Newser
Does Zevra Therapeutics Inc. qualify in momentum factor screening2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser
Risk adjusted return profile for Zevra Therapeutics Inc. analyzedWeekly Investment Recap & Weekly Return Optimization Plans - Newser
Is It Too Early to Call Recovery in Zevra Therapeutics Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Zevra Therapeutics Faces $58.7 Million Impairment Charge, Raising Concerns Over Financial Stability - MSN
Tools to monitor Zevra Therapeutics Inc. recovery probabilityPortfolio Gains Summary & Advanced Technical Analysis Signals - Newser
Zevra Therapeutics Inc Azioni (ZVRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Zevra Therapeutics Inc Azioni (ZVRA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Thompson Rahsaan | Chief Legal & Compliance |
Jun 26 '25 |
Sale |
9.21 |
24,000 |
221,004 |
42,666 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):